1-5 of 5
Ruth Langholm
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Clinical Trials & Observations
Christian H. Geisler, Arne Kolstad, Anna Laurell, Niels S. Andersen, Lone B. Pedersen, Mats Jerkeman, Mikael Eriksson, Marie Nordström, Eva Kimby, Anne Marie Boesen, Outi Kuittinen, Grete F. Lauritzsen, Herman Nilsson-Ehle, Elisabeth Ralfkiær, Måns Åkerman, Mats Ehinger, Christer Sundström, Ruth Langholm, Jan Delabie, Marja-Liisa Karjalainen-Lindsberg, Peter Brown, Erkki Elonen, for the Nordic Lymphoma Group
Journal: Blood
Blood (2008) 112 (7): 2687–2693.
https://doi.org/10.1182/blood-2008-03-147025
Published: 2008
Journal Articles

Mantle Cell Lymphoma Can Be Cured by Intensive Immunochemotherapy with In-Vivo Purged Stem-Cell Support; Final Report of the Nordic Lymphoma Group MCL2 Study.

Christian H. Geisler, MD, PhD, Erkki Elonen, MD, PhD, Arne Kolstad, MD, PhD, Anna Laurell, MD, PhD, Niels Andersen, MD, PhD, Lone B. Pedersen, B.Sc, Anne Marie Boesen, MD, Phd, Mikael Eriksson, MD, PhD, Mats Jerkeman, MD, PhD, Eva Kimby, MD, PhD, Outi Kuittinen, MD, PhD, Grethe F. Lauritzen, MD, PhD, Herman Nilsson-Ehle, MD, PhD, Marie Nordström, MD, PhD, Elisabeth Ralfkiaer, MD, PhD, Måns Åkerman, MD, PhD, Mats Ehinger, MD, PhD, Christer Sundström, MD, PhD, Ruth Langholm, MD, PhD, Jan Delabie, MD, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD, Peter Brown, MD, PhD
Journal: Blood
Blood (2007) 110 (11): LB1.
https://doi.org/10.1182/blood.V110.11.LB1.lb1
Published: 2007
Journal Articles

Nordic Mantle Cell Lymphoma (MCL) Project: Preemptive Rituximab Treatment of Molecular Relapse Following Autotransplant Can Reinduce Molecular Remission and Prolonged Disease-Free Survival.

Christian H. Geisler, MD, PhD, Erkki Elonen, MD, Ph.D, Arne Kolstad, MD, Ph.D, Anna Laurell, MD, Ph.D, Lone B. Pedersen, B of Sc, Niels S. Andersen, MD, Ph.D, Mats Jerkeman, MD, Ph.D, Marie Nordstrom, MD, Ph.D, Grethe F. Lauritzen, MD, Ph.D, Elisabeth Ralfkiaer, MD, Ph.D, Maans Akerman, MD, Ph.D, Christer Sundstrom, MD, Ph.D, Ruth Langholm, MD, Ph.D, Marja-Liisa Karjalainen-Lindsberg, MD, Ph.D, Outti Kuittinen, MD, Ph.D, Mikael Eriksson, MD, Ph.D, Nordic Lymphoma Group
Journal: Blood
Blood (2005) 106 (11): 2429.
https://doi.org/10.1182/blood.V106.11.2429.2429
Published: 2005
Journal Articles

Nordic Mantle Cell Lymphoma (MCL) Project: Prolonged Follow-Up of 86 Patients Treated with BEAM/BEAC + PBSCT Confirms That Addition of High-Dose Ara-C and Rituximab to CHOP Induction + In-Vivo Purging with Rituximab Increases Clinical and Molecular Response Rates, PCR-Neg. Grafts, Failure-Free, Relapse-Free and Overall Survival.

Christian H. Geisler, MD, PhD, Erkki Elonen, MD, PhD, Arne Kolstad, MD, PhD, Anna Laurell, MD, PhD, Niels S. Andersen, MD, PhD, Lone B. Pedersen, Mats Jerkeman, MD, PhD, Marie Nordstroem, MD, PhD, Grete F. Lauritzen, MD, PhD, Elisabeth Ralfkiaer, MD, PhD, Maans Aakerman, MD, PhD, Christer Sundstroem, MD, PhD, Ruth Langholm, MD, PhD, Marja-Liisa Karjalainen-Lindsberg, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 8.
https://doi.org/10.1182/blood.V104.11.8.8
Published: 2004
Journal Articles

Rituximab for primary chronic cold agglutinin disease: a prospective study of 37 courses of therapy in 27 patients

Clinical Trials & Observations
Sigbjørn Berentsen, Elling Ulvestad, Bjørn Tore Gjertsen, Henrik Hjorth-Hansen, Ruth Langholm, Håvar Knutsen, Waleed Ghanima, Fuad Victor Shammas, Geir E. Tjønnfjord
Journal: Blood
Blood (2004) 103 (8): 2925–2928.
https://doi.org/10.1182/blood-2003-10-3597
Published: 2004